Discovery of potential WEE1 inhibitors via hybrid virtual screening

Discovery of potential WEE1 inhibitors via hybrid virtual screening

G2/M cell cycle checkpoint protein WEE1 kinase is a promising target for inhibiting tumor growth. Although various WEE1 inhibitors have entered clinical investigations, their therapeutic efficacy and safety profile remain unsatisfactory. In this study, we employed a comprehensive virtual screening w...

Full description

Bibliographic Details
Main Authors:	Tingting Jin, Wei Xu, Roufen Chen, Liteng Shen, Jian Gao, Lei Xu, Xinglong Chi, Nengming Lin, Lixin Zhou, Zheyuan Shen, Bo Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Pharmacology
Subjects:	virtual screening WEE1 molecular dynamics geometric deep learning cell cycle
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1298245/full

Similar Items

A hybrid energy-based and AI-based screening approach for the discovery of novel inhibitors of JAK3
by: Juying Wei, et al.
Published: (2023-10-01)

A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
by: Andrea Ghelli Luserna di Rorà, et al.
Published: (2020-09-01)

Targeting WEE1 Kinase in Gynecological Malignancies
by: Zhang W, et al.
Published: (2024-06-01)

Wee1 inhibitor PD0166285 sensitized TP53 mutant lung squamous cell carcinoma to cisplatin via STAT1
by: Qi Li, et al.
Published: (2024-09-01)

Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
by: Wenwen Chien, et al.
Published: (2023-04-01)

Fission yeast Wee1 is required for stable kinetochore-microtubule attachment
by: Masahiro Takado, et al.
Published: (2024-01-01)

Novel insights into maintaining genomic integrity: Wee1 regulating Mus81/Eme1
by: Martín Yusé, et al.
Published: (2011-12-01)

LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma
by: Xuqiang Zhu, et al.
Published: (2023-02-01)

WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment
by: Seiichi Okabe, et al.
Published: (2023-06-01)

Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process
by: Yu-Li Su, et al.
Published: (2023-05-01)

Insights from 25 years of research by Bert van Wee published in the European Journal of Transport and Infrastructure Research
by: Maaike Snelder, et al.
Published: (2025-01-01)

Caffeine Stabilises Fission Yeast Wee1 in a Rad24-Dependent Manner but Attenuates Its Expression in Response to DNA Damage
by: John P. Alao, et al.
Published: (2020-09-01)

Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening
by: Chenpeng Yao, et al.
Published: (2023-10-01)

Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
by: Hayden L. Bell, et al.
Published: (2023-09-01)

Combined inhibition of Wee1 and Chk1 as a therapeutic strategy in multiple myeloma
by: Angélique Bruyer, et al.
Published: (2023-12-01)

Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma
by: Md Obaidul Islam, et al.
Published: (2023-09-01)

Combined inhibition of ribonucleotide reductase and WEE1 induces synergistic anticancer activity in Ewing’s sarcoma cells
by: Judy Ziener, et al.
Published: (2025-02-01)

PEMAHAMAN KONSEP MATEMATIS MELALUI MODEL WEE DENGAN STRATEGI QSH DITINJAU DARI SELF REGULATION
by: Tri Wahyuni, et al.
Published: (2019-05-01)

PD0166285 sensitizes esophageal squamous cell carcinoma to radiotherapy by dual inhibition of WEE1 and PKMYT1
by: Qingyi Zhang, et al.
Published: (2022-11-01)

G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells
by: Meryem H. Cetin, et al.
Published: (2023-01-01)

Within variety flowering time variation leads to yield variation in Sri Lankan traditional rice “Sudu wee”
by: E. U. U. Rathnathunga, et al.
Published: (2016-09-01)

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
by: Andrea Ghelli Luserna Di Rorà, et al.
Published: (2018-08-01)

Combined evaluation of both WEE1 and phosphorylated cyclin dependent kinase 1 expressions in oral squamous cell carcinomas predicts cancer recurrence and progression
by: Yu-Hsueh Wu, et al.
Published: (2022-10-01)

The sociopragmatic study of speech acts in Go’et Ira in the We’e Mbaru cultural rite
by: Gabriel Fredi Daar
Published: (2023-05-01)

Structure-Based Virtual Screening towards the Discovery of Novel ULK1 Inhibitors with Anti-HCC Activities
by: Yang Gao, et al.
Published: (2022-04-01)

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
by: Agnes Oetting, et al.
Published: (2023-07-01)

Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening
by: Chujiao Hu, et al.
Published: (2022-09-01)

PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
by: Andrä Brunner, et al.
Published: (2020-07-01)

miR-526b-3p serves as a prognostic factor and regulates the proliferation, invasion, and migration of glioma through targeting WEE1
by: Wu M, et al.
Published: (2019-04-01)

Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
by: Vibhu Jha, et al.
Published: (2020-12-01)

Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1/CDK1/cyclin B1 axis
by: Jie Feng, et al.
Published: (2024-12-01)

Virtual screening for the discovery of lawsone derivatives as PS Ⅱ inhibitors
by: Qingqing Wang, et al.
Published: (2024-10-01)

C/EBPβ Is a Transcriptional Regulator of Wee1 at the G<sub>2</sub>/M Phase of the Cell Cycle
by: Ji Hae Lee, et al.
Published: (2019-02-01)

Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening
by: Elena M. Loi, et al.
Published: (2022-03-01)

Total fertilization failure with in vitro fertilization-intracytoplasmic sperm injection related to WEE2 mutation highlights emerging importance of genetic causes of in vitro fertilization failure
by: Hillary S. Weiner, M.B.E., et al.
Published: (2022-12-01)

Wee1 promotes cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1
by: Fanting Zeng, et al.
Published: (2022-12-01)

Identification of Novel Covalent XPO1 Inhibitors Based on a Hybrid Virtual Screening Strategy
by: Zheyuan Shen, et al.
Published: (2022-04-01)

HREM, RNAseq and Cell Cycle Analyses Reveal the Role of the G2/M-Regulatory Protein, WEE1, on the Survivability of Chicken Embryos during Diapause
by: Narayan Pokhrel, et al.
Published: (2022-03-01)

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
by: Manuela Mancini, et al.
Published: (2022-08-01)

Simultaneously expressed miR-424 and miR-381 synergistically suppress the proliferation and survival of renal cancer cells---Cdc2 activity is up-regulated by targeting WEE1
by: Binghai Chen, et al.
Published: (2013-06-01)